SOURCE: CISION PR Newswire
CDI Labs' Dr Tyler Hulett Ph.D. joins global Cancer Grand Challenges team taking on the cancer avoidance challengeThe team, which is led from Institut Imagine by Paul Bastard, will receive up to $25m over approximately five years to take on the challenge of cancer avoidance.
READ MORESOURCE: CISION PR Newswire
CDI Labs Launches Pan-isotype Analysis of Serum Autoantibodies to Unlock Critical New Insights Into Humoral ImmunityNew Offering Allows Researchers to Interrogate all Antibody Isotypes and Subclasses when using CDI Labs HuProt™ Human Proteome Microarray and VirScan® PhIP-Seq Antibody Profiling Services
READ MORESOURCE: CISION PR Newswire
CDI Labs Canada Launches Hormone-focused PhIP-Seq Library for Highly Multiplexed Analysis of Serum AutoantibodiesNew Offering Allows Researchers to Interrogate Autoantibody Responses Against Peptide Hormones and Hormone Fragments Using CDI Labs Canada’s Phage Display Immunoprecipitation Sequencing (PhIP-Seq) Services
READ MORESOURCE: Pharma Boardroom
Interview on Pharma Boardroom with Dr. Ignacio Pino – Co-Founder and COO, CDI LabsDr. Ignacio Pino, Co-founder and COO at CDI Labs, shares his inspiring journey and the visionary mission behind establishing CDI Labs.
READ MORESOURCE: CDI Labs Grant Program 2024
Dr. Donald Vinh at McGill University Health Science Centre Selected as the Winner of CDI Labs Grant Program 2024 READ MORESOURCE: The Washington Post
Why does it feel like everyone has an autoimmune disease?Autoimmune diseases are rising worldwide, and it’s not purely explained by genetics.
READ MORESOURCE: CISION PR Newswire
CDI Labs Launches New VirScan, HuScan, and MouseScan Services for Massively Multiplexed Analysis of Serum AntibodiesNew Services Use Phage Display Immunoprecipitation Sequencing (PhIP-Seq) to Provide Groundbreaking High-throughput, Proteome-wide Seromic Analysis
READ MORESOURCE: CISION PR Newswire
Barney E. Saunders Ph.D. has been appointed Chief Executive Officer of CDI Laboratories READ MORESOURCE: CISION PR Newswire
BroadOak Capital Partners Invests in CDI Laboratories to Expand and Scale Antibody Biomarker Discovery PlatformsThe investment will support the expansion of CD's technology platforms to service more customers.
READ MORESOURCE: CISION PR Newswire
CDI Labs HuProt™ Protein Arrays Instrumental in Recent Study of Multisystem Inflammatory Syndrome in Children (MIS-C)Proteomics company CDI Laboratories products used in important study of MIS-C and its relationship to SARS-CoV-2 (COVID-19) infection.
READ MORE1
2